GlassScriptPhysician profile
Stephanie Lerner
NPI 1619612157
$5,294.41
in general payments reported to CMS, 2019-2025
24 companies · $693 in 2025
The $693 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $715 · 2023: $2,289 · 2024: $1,597 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,318 · Education: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,317.69 |
| Education | $261.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,225.58 | 2022-2025 | Breztri, Airsupra, Fasenra |
| Inogen, INC. | $882.35 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $736.54 | 2022-2025 | Ofev, Stiolto Respimat |
| Glaxosmithkline, LLC. | $609.54 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Actelion Pharmaceuticals US, INC. | $328.20 | 2022-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $263.66 | 2022-2025 | Dupixent |
| Amgen INC. | $203.16 | 2023-2025 | Tezspire |
| Mylan Specialty L.P. | $169.28 | 2023-2024 | Yupelri |
| United Therapeutics Corporation | $118.76 | 2022-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $112.58 | 2023-2025 | Arikayce |
| Janssen Pharmaceuticals, INC | $90.76 | 2023-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $84.99 | 2024 | |
| Verona Pharma, INC. | $84.06 | 2025 | Ohtuvayre |
| Covis Pharma Gmbh | $81.81 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $60.83 | 2024 | Dificid, Zerbaxa |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $46.62 | 2024-2025 | Purified Cortrophin Gel |
| Paratek Pharmaceuticals, INC. | $37.05 | 2023-2024 | Nuzyra |
| Pulmonx Corporation | $29.96 | 2022 | |
| Philips North America LLC | $27.46 | 2024 | (Ak6) Vest Therapy |
| Alnylam Pharmaceuticals INC. | $23.94 | 2024 | Givlaari |
| Bayer Healthcare Pharmaceuticals INC. | $21.60 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.22 | 2025 | Relistor |
| Vapotherm INC | $18.75 | 2022 | |
| Genzyme Corporation | $16.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.